THERESA SEARLS: Open Payments
NPI 1154564003 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 28 payments from 11 companies in 2025. Trend: 2023 $303 · 2024 $1,079 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $275 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Alkermes, Inc. | 1 | $23 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: COBENFY, INGREZZA, Qelbree, ABILIFY ASIMTUFII, VRAYLAR, Jornay PM, FANAPT, ARISTADA.
Industry payments across VA — which companies pay providers there.
